Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio M Risitano

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Blood|May 27, 2017
Immune insights into AAAntonio M Risitano
Blood|October 5, 2019
T-PLL: harmonizing criteria for researchAntonio M Risitano
Blood|December 30, 2021
HLA in AA: innocent bystander or culprit?Antonio M Risitano
British Journal of Haematology|December 2, 2010
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are goingAntonio M Risitano
Blood|April 13, 2023
PNH and complement gene variantsAntonio M Risitano
Immunobiology|September 12, 2012
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disordersAntonio M Risitano
Hematology/Oncology Clinics of North America|June 5, 2015
Current and future pharmacologic complement inhibitorsAntonio M Risitano
Seminars in Hematology|July 24, 2018
Therapeutic complement modulation for hematological diseases: Where we stand and where we are goingAntonio M Risitano
Haematologica|May 2, 2018
(Auto-)immune signature in aplastic anemiaAntonio M Risitano
Current Opinion in Hematology|December 7, 2011
Immunosuppressive therapies in the management of acquired immune-mediated marrow failuresAntonio M Risitano
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Blood|May 27, 2017
Immune insights into AAAntonio M Risitano
Blood|October 5, 2019
T-PLL: harmonizing criteria for researchAntonio M Risitano
Blood|December 30, 2021
HLA in AA: innocent bystander or culprit?Antonio M Risitano
British Journal of Haematology|December 2, 2010
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are goingAntonio M Risitano
Blood|April 13, 2023
PNH and complement gene variantsAntonio M Risitano
Immunobiology|September 12, 2012
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disordersAntonio M Risitano
Hematology/Oncology Clinics of North America|June 5, 2015
Current and future pharmacologic complement inhibitorsAntonio M Risitano
Seminars in Hematology|July 24, 2018
Therapeutic complement modulation for hematological diseases: Where we stand and where we are goingAntonio M Risitano
Haematologica|May 2, 2018
(Auto-)immune signature in aplastic anemiaAntonio M Risitano
Current Opinion in Hematology|December 7, 2011
Immunosuppressive therapies in the management of acquired immune-mediated marrow failuresAntonio M Risitano
Pageof 14